Litcius/Paper detail

Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study

Raquel Espinosa-Cárdenas, Asiel Arce-Sillas, Diana Denisse Álvarez‐Luquín, Jaquelín Leyva-Hernández, Esteban Uriel Montes-Moratilla, I Gonzalez-Saavedra, Marie‐Catherine Boll, Elizabeth García-García, Sandra Ángeles-Perea, Gladis Fragoso, Edda Sciutto, Laura Adalid‐Peralta

2020Journal of Neuroimmunology32 citationsDOI

Topics & Concepts

PramipexoleLevodopaParkinson's diseaseDopaminergicMedicineImmune systemDiseasePharmacologyDopamineImmunologyInternal medicineParkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsNerve injury and regeneration
Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study | Litcius